These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 29314582

  • 1. Transcoronary concentration gradients of circulating microRNAs in heart failure.
    De Rosa S, Eposito F, Carella C, Strangio A, Ammirati G, Sabatino J, Abbate FG, Iaconetti C, Liguori V, Pergola V, Polimeni A, Coletta S, Gareri C, Trimarco B, Stabile G, Curcio A, Indolfi C, Rapacciuolo A.
    Eur J Heart Fail; 2018 Jun; 20(6):1000-1010. PubMed ID: 29314582
    [Abstract] [Full Text] [Related]

  • 2. Transcoronary concentration gradients of circulating microRNAs.
    De Rosa S, Fichtlscherer S, Lehmann R, Assmus B, Dimmeler S, Zeiher AM.
    Circulation; 2011 Nov 01; 124(18):1936-44. PubMed ID: 21969012
    [Abstract] [Full Text] [Related]

  • 3. Transcoronary gradients of vascular miRNAs and coronary atherosclerotic plaque characteristics.
    Leistner DM, Boeckel JN, Reis SM, Thome CE, De Rosa R, Keller T, Palapies L, Fichtlscherer S, Dimmeler S, Zeiher AM.
    Eur Heart J; 2016 Jun 07; 37(22):1738-49. PubMed ID: 26916800
    [Abstract] [Full Text] [Related]

  • 4. Transcoronary Concentration Gradient of microRNA-133a and Outcome in Patients With Coronary Artery Disease.
    De Rosa R, De Rosa S, Leistner D, Boeckel JN, Keller T, Fichtlscherer S, Dimmeler S, Zeiher AM.
    Am J Cardiol; 2017 Jul 01; 120(1):15-24. PubMed ID: 28511772
    [Abstract] [Full Text] [Related]

  • 5. Transcoronary gradient of plasma microRNA 423-5p in heart failure: evidence of altered myocardial expression.
    Goldraich LA, Martinelli NC, Matte U, Cohen C, Andrades M, Pimentel M, Biolo A, Clausell N, Rohde LE.
    Biomarkers; 2014 Mar 01; 19(2):135-41. PubMed ID: 24506564
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Analysis of circulating microRNAs in patients with repaired Tetralogy of Fallot with and without heart failure.
    Abu-Halima M, Meese E, Keller A, Abdul-Khaliq H, Rädle-Hurst T.
    J Transl Med; 2017 Jul 10; 15(1):156. PubMed ID: 28693530
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of circulating microRNAs on heart failure-related morbidity and mortality in two large diverse cohorts of general heart failure patients.
    Bayés-Genis A, Lanfear DE, de Ronde MWJ, Lupón J, Leenders JJ, Liu Z, Zuithoff NPA, Eijkemans MJC, Zamora E, De Antonio M, Zwinderman AH, Pinto-Sietsma SJ, Pinto YM.
    Eur J Heart Fail; 2018 Jan 10; 20(1):67-75. PubMed ID: 28949058
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identifying differential miR and gene consensus patterns in peripheral blood of patients with cardiovascular diseases from literature data.
    Šatrauskienė A, Navickas R, Laucevičius A, Huber HJ.
    BMC Cardiovasc Disord; 2017 Jun 30; 17(1):173. PubMed ID: 28666417
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure.
    van Boven N, Kardys I, van Vark LC, Akkerhuis KM, de Ronde MWJ, Khan MAF, Merkus D, Liu Z, Voors AA, Asselbergs FW, van den Bos EJ, Boersma E, Hillege H, Duncker DJ, Pinto YM, Postmus D.
    Eur J Heart Fail; 2018 Jan 30; 20(1):89-96. PubMed ID: 28948688
    [Abstract] [Full Text] [Related]

  • 14. Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome.
    Wang A, Kwee LC, Grass E, Neely ML, Gregory SG, Fox KAA, Armstrong PW, White HD, Ohman EM, Roe MT, Shah SH, Chan MY.
    Atherosclerosis; 2017 Jun 30; 261():19-25. PubMed ID: 28437675
    [Abstract] [Full Text] [Related]

  • 15. Circulating microribonucleic acids miR-1, miR-21 and miR-208a in patients with symptomatic heart failure: Preliminary results.
    Sygitowicz G, Tomaniak M, Błaszczyk O, Kołtowski Ł, Filipiak KJ, Sitkiewicz D.
    Arch Cardiovasc Dis; 2015 Dec 30; 108(12):634-42. PubMed ID: 26498537
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders.
    Marfella R, Di Filippo C, Potenza N, Sardu C, Rizzo MR, Siniscalchi M, Musacchio E, Barbieri M, Mauro C, Mosca N, Solimene F, Mottola MT, Russo A, Rossi F, Paolisso G, D'Amico M.
    Eur J Heart Fail; 2013 Nov 30; 15(11):1277-88. PubMed ID: 23736534
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.